Belgian Patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be): Data, Scores, and Phenotypes since 2015
Dermatology · 2024
DOI: 10.1159/000538804 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatology, 2024. Verfasst von Stephanie Heudens und 10 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, HUB - Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium, stephanie.heudens@ulb.be. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Registries, Phenotype, Severity of Illness Index. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 66 Literaturangaben.
Abstract (Originalsprache)
Introduction
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease, characterized by painful and recurrent lesions in apocrine gland-bearing skin areas. It is a heterogeneous disease, which makes assessment and data collection difficult. Questionnaires with detailed items, such as the Belgian European Registry for Hidradenitis Suppurativa (ERHS-Be), are useful to study HS and its associated comorbidities. The aim of this registry was to uncover new factors associated with HS and understand HS patients’ clinical profiles and efficacy of treatments. Material and Methods: The ERHS-Be registry is based on questionnaires, with sections for sociodemographic data, medical and HS history, clinical examination, and treatment plan. It allows identification of different clinical phenotypes and automatic calculation of severity scores.
Results
At present, 606 patients are included in the ERHS-Be (67% women, 33% men). The mean age at the first visit is 38.5 years. Tobacco use is present in 72.6% of patients. A family history of HS is noted in 42% of patients. Comorbidities are documented in this cohort: depression is present in 43.8% of patients, arthritis in 27.8%, obesity in 31.5%, hypertension in 10.6%, diabetes mellitus in 6.4%, and dyslipidemia in 12.4%. Moreover, 7.7% of patients suffer from IBD and 27.4% have a pilonidal sinus. History of severe acne is found in 32.1% of patients and psoriasis in 9.3%. Thirteen percent of women in our cohort suffer from polycystic ovarian syndrome. Severity of disease is quantified in 533 patients: for instance, Hurley I, II, and III scores proportions are, respectively, 32.3%, 52.7%, and 15%, while the mean IHS4 score is 5.2. This registry also enables determination of relative phenotype proportions in our cohort, according to different classifications.
Conclusion
The ERHS-Be questionnaires allow systematic and larger data collection, including detailed comorbidities, phenotypes, and severity of disease. Analysis of this large database will contribute to a better understanding and management of HS, at a time where new therapeutic options are becoming available.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dermatology Department, HUB - Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium, stephanie.heudens@ulb.be.
- Dermatology Department, HUB - Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Zitieren
APA
Heudens, S., Sarkis, A. S., Daoud, M., Daxhelet, M., Benhadou, F., Suppa, M., Nobile, L., Karama, J., Njimi, H., White, J. M., & Del Marmol, V. (2024). Belgian Patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be): Data, Scores, and Phenotypes since 2015. Dermatology. https://doi.org/10.1159/000538804
Vancouver
Heudens S, Sarkis AS, Daoud M, Daxhelet M, Benhadou F, Suppa M, et al. Belgian Patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be): Data, Scores, and Phenotypes since 2015. Dermatology. 2024. doi:10.1159/000538804
BibTeX
@article{Heudens2024,
author = {Heudens, Stephanie and Sarkis, Anne-Sophie and Daoud, Mathieu and Daxhelet, Mathilde and Benhadou, Farida and Suppa, Mariano and Nobile, Laura and Karama, Jalila and Njimi, Hassane and White, Jonathan M and Del Marmol, Veronique},
title = {Belgian Patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be): Data, Scores, and Phenotypes since 2015},
journal = {Dermatology},
year = {2024},
doi = {10.1159/000538804}
}
EUVIMED